Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer.

Wang, Yunzhen; Huang, Sha; Feng, Xiangwei; Xu, Wangjue; Luo, Raojun; Zhu, Ziyi; Zeng, Qingxin; He, Zhengfu

Wang, Yunzhen; Huang, Sha; Feng, Xiangwei; Xu, Wangjue; Luo, Raojun; Zhu, Ziyi; Zeng, Qingxin; He, Zhengfu.

Afiliación

Wang Y; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huang S; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Feng X; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xu W; Department of Thoracic Surgery, Longyou County People's Hospital, Longyou, China.
Luo R; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhu Z; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zeng Q; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
He Z; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Front Oncol ; 13: 1145128, 2023.

Article en En | MEDLINE | ID: mdl-37265800

Palabras clave

biomarkers; chemo-immunotherapy; efficacy prediction; neoadjuvant immunotherapy; non-small cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google